Nearly all EU member states have interpreted article 13 of the European TPD to ban all claims related to health in the absence of a medical certificate. However, there may be a pathway to a reduced-risk classification. ...
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
CBD as a Novel Food: the future for edibles in Europe
Avoid the risks of online misinformation. This report, from our sister platform CBD-Intel, provides an exclusive in-depth analysis with practical information for your business. All you need to know about CBD and Novel Foods in one place!
Do you want to understand the industry impact of Novel Food regulations and future scenarios? Then you cannot miss our new report.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
